Real-world study shows power of Pfizer, Moderna vaccines to prevent COVID-19
Jun 08, 2021
Symptomatic and asymptomatic infection was reduced by 81% after partial vaccination and by 91% after full vaccination
Omicron variant may overcome prior COVID-19 infection
Dec 03, 2021
Researchers found a jump in repeat infections with the new omicron variant that did not occur with two previous variants.
Moderna vaccine may shield more against breakthrough infections than Pfizer: study
Aug 12, 2021
The Mayo Clinic researchers found that in Minnesota last month, the Moderna vaccine was 76% effective at preventing a breakthrough infection, whereas the Pfizer vaccine was only 42% effective.
FDA panel backs Pfizer RSV vaccine for older Americans
Mar 01, 2023
Pfizer has reported that its vaccine would reduce risk from RSV by as much as 86%.
FDA gives Moderna COVID-19 vaccine full approval
Jan 31, 2022
Vaccine, which has been available for the age group under emergency use authorization, will be marketed as Spikevax.
SARS-CoV-2 shot continues to prevent infection, hospitalization with delta variant
Aug 26, 2021
The SARS-CoV-2 infection rate and hospitalization rate was 4.9 and 29.2 times higher for unvaccinated versus fully vaccinated persons.
COVID-19 infection, vaccination have little effect on migraine worsening
Oct 04, 2023
An increased concern about migraine worsening was a risk factor for perceived migraine worsening.
Infections reported after single dose of monkeypox vaccine
Oct 04, 2022
Most of the cases of monkeypox occurring following single dose of the MVA-BN vaccine occur within 14 days.
COVID-19 vaccination tied to decline in distress in U.S. adults
Feb 24, 2022
Decreases in distress and perceived risks for infection, hospitalization and death were reported by those receiving at least one dose of the vaccine.
COVID-19 vaccine effectiveness changing with delta predominance
Sep 14, 2021
Vaccine protection against SARS-CoV-2 infection declined; protection remained higher against hospitalization, death.
